摘要
Abstract
Objective To explore the clinic effect of recombinant human interferon α-2b in treatment of chronic hep-atitis C. Methods A total of 100 cases of chronic hepatitis C in our hospital from April 2009 to April 2014 were divided into recombinant human interferon α-2b treatment ﹙observation group,n=50) with ordinary -2b interferon treatment﹙control group, n=50),and the effects were compared. Results After treatment,both groups anorexia, nausea, fever, chills,body pain, fatigue,cough cough,nasal congestion,sore throat and other symptoms, symptomatic treatment, were all disappeared. Two groups of patients had few neutrophils and leukopenia, take up the white drug applications, re-turned to normal,alopecia:observation group 1 case, group 2 cases,the drug improved after the closure. ALT normaliza-tion rates of observation group treatment for 12 weeks,24 weeks and 24 weeks were higher than control group, the dif-ference was statistically significant after treatment ﹙P<0.05). Conclusion Chronic hepatitis C using recombinant hu-man interferonα-2b therapy,can significantly improve the prognosis, protect the quality of life of patients.关键词
重组人干扰素α-2b/慢性丙型肝炎/临床效果Key words
Recombinant human interferonα-2b/Chronic hepatitis C/Clinical effect分类
医药卫生
